To find out if your plan covers Wegovy, check your plans formulary online or call the customer service number on the back of your insurance card to verify whether Wegovy is covered for weight management
On December 22, 2025, the FDA approved Novo Nordisk's once-daily oral semaglutide (Wegovy pill, 25 mg) for chronic weight management and cardiovascular risk reduction (FDA / Novo Nordisk, 2025)
That means you cannot rely on a known benefit or a known risk profile when using a compounded version
Important safety information includes a boxed warning for thyroid C-cell tumors and warnings for pancreatitis, gallbladder disease, acute kidney injury, and suicidal behavior and ideation
These may include: Referral from a primary care provider Pre-authorization for certain treatments Documentation of medical necessity Failure to follow these steps may result in denied claims or higher out-of-pocket costs
By the time of 6 months, the weight loss was around 12.3 kg